Welcome to the CEO Cancer Gold Standard Website

Welcome to the web site for the CEO Cancer Gold Standard, an initiative of the CEO Roundtable on Cancer. Created by Roundtable Member CEOs, the CEO Cancer Gold Standard defines what CEOs and their organizations can do to prevent cancer, to detect it early, and to ensure access to the best available treatment for those who are diagnosed with cancer. It is our hope that visitors to this Web site will learn about the CEO Cancer Gold Standard and adopt it within their organizations. Please join us in the fight against cancer.

Information for CEOs

What CEOS should know about the CEO Cancer Gold Standard.

Learn More
News

Minot State University Receives CEO Cancer Gold StandardTM accreditation

June 10, 2009
Minot State University was accredited with the CEO Cancer Gold Standard™ certification, recognizing the organization’s commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.
Read More

Millennium: The Takeda Oncology Company Receives CEO Cancer Gold Standard™ accreditation

April 23, 2009
Millennium: The Takeda Oncology Company was accredited with the CEO Cancer Gold Standard™ certification, recognizing the company’s commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.
Read More

GOLD STANDARD FOCUS

‘Wellness at Wistar’ Program Promotes Healthy Lifestyles, Cancer Prevention

The Wistar Institute, an international leader in biomedical research with expertise in cancer research and vaccine development, was accredited in August 2008, with the CEO Cancer Gold Standard™ from the CEO Roundtable on Cancer, in recognition of its efforts to improve the health of employees and their families and reduce their risks of cancer.

Click here to read more.

Did You Know?

Mammography can detect breast cancer at an early stage, when treatment may be more effective and survival is more likely.